GlassScriptPhysician profile
Jill E Jacoski
NPI 1841549102
$1,597.26
in general payments reported to CMS, 2019-2025
15 companies · $782 in 2025
The $782 reported for 2025 was more than what 84% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $183 · 2023: $193 · 2024: $440 · 2025: $782.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,414.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,414.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $300.76 | 2021-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Alnylam Pharmaceuticals INC. | $297.14 | 2025 | Amvuttra |
| Kestra Medical Technology Services, INC. | $220.70 | 2024-2025 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $126.15 | 2024 | Eliquis |
| Abiomed | $120.36 | 2024 | Impella |
| Amgen INC. | $120.29 | 2024 | Repatha |
| Novo Nordisk INC | $110.45 | 2025 | Ozempic |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $98.65 | 2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $56.07 | 2025 | Wainua |
| Medtronic, INC. | $45.10 | 2021 | |
| Novartis Pharmaceuticals Corporation | $29.70 | 2023 | |
| Hologic Sales and Service, LLC | $21.94 | 2025 | Myosure Tissue Removal Device |
| Abbott Laboratories | $17.24 | 2025 | Merlin@Home |
| Esperion Therapeutics, INC. | $16.52 | 2024 | Nexletol |
| Heartflow, INC. | $16.19 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Jacoski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.